Product

APIs with DMF / COS or European Registered Drug Dossiers are suitably indicated in brackets. [Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer’s risk.]

PRODUCT NAME PHARMACOPOEIA STATUS REGULATORY APPROVAL THERAPEUTIC CLASS
REGULAR APIs
Homatropine Methyl Bromide BP, USP, EP USDMF # 23963 and EDMF filed EU GMP, USFDA Anticholinergic medication
Mydriatic and cycloplegic
Dexketoprofen Trometamol IHS USDMF # 26959 GMP, MFDS Analgesic
Atropine Sulfate USP, EP USDMF # 29605, CEP available and EDMF filed CEP
EU GMP
Mydriatic and cycloplegic
Diethyl Carbamazine Citrate USP, EP WHO Geneva approved,
USDMF # 26954
EU GMP, WHO Anthelmintic
Levofloxacin Hemihydrate USP, JP, IHS,EP EDMF & JDMF available EUGMP Broad Spectrum Antibiotic
Homatropine Hydro Bromide BP, USP, EP DMF available GMP Anticholinergic medication
Mydriatic and cycloplegic
Ketorolac Tromethamine EP, USP DMF available GMP Analgesic
Pregabalin (in tie up with Pharmathen) IHS EDMF, USDMF to be filed GMP Anticonvulsant drug
Clopidogrel Besylate
(in tie up with Pharmathen)
IHS EDMF to be filed GMP Antiplatelet
Febuxostat
(in tie up with Pharmathen)
IHS EDMF to be filed GMP Xanthine oxidase inhibitor
Dex Rabeprazole IHS DMF available GMP Proton pump inhibitor
Vildagliptin (in tie up with Pharmathen) IHS DMF available GMP Anti-hyperglycemic agent
Loxoprofen Sodium JP JDMF available GMP Non-steroidal anti-inflammatory drug, or NSAID
Rebamipide JP JDMF available GMP Treatment of gastric Ulcers
Ketoprofen EP, USP DMF available GMP Non-steroidal anti-inflammatory drug, or NSAID
UNDER VALIDATION
Obidoxime Hydrochloride EP Q2-2019 Antidote: Cholinesterase reactivator
Ipratropium bromide USP, EP Q2-2019 Bronchodilator
Clopidogrel Bisulfate
( Form I & Form II)
USP DMF available Antiplatelet
Alpha Lipoic Acid USP, EP Q3–2019 Antioxidant
Nitisinone IHS Samples available 4-hydroxyphenylpyruvate dioxygenase
R-Alpha Lipoic acid EP Q3–2019 Antioxidant
Cycloserine USP, IP Q2–2019 Bactericidal or Bacteriostatic
UNDER DEVELOPMENT
Tiotropium Anhydrous IHS Samples available Antimuscarinics/ Antispasmodics
Ramelteon IHS Samples available Melatonin receptor agonists
Nebivolol EP Development Started Antihypertensive
Vasodilating Agents
Selexipag IHS Peripheral Vasodilator
Empagliflozin Antidiabetic: Sodium glucose co-transporter-2 (SGLT-2) inhibitor
Dapagliflozin Antidiabetic

Disclaimer: Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement. The liability of any sale into such protected markets is at buyer’s risk.